BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7898938)

  • 1. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase.
    Borg JP; deLapeyrière O; Noguchi T; Rottapel R; Dubreuil P; Birnbaum D
    Oncogene; 1995 Mar; 10(5):973-84. PubMed ID: 7898938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.
    Pajusola K; Aprelikova O; Pelicci G; Weich H; Claesson-Welsh L; Alitalo K
    Oncogene; 1994 Dec; 9(12):3545-55. PubMed ID: 7970715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor.
    Fournier E; Dubreuil P; Birnbaum D; Borg JP
    Oncogene; 1995 Sep; 11(5):921-31. PubMed ID: 7675451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
    Pajusola K; Aprelikova O; Armstrong E; Morris S; Alitalo K
    Oncogene; 1993 Nov; 8(11):2931-7. PubMed ID: 7692369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of murine Flt4 ligand/VEGF-C.
    Fitz LJ; Morris JC; Towler P; Long A; Burgess P; Greco R; Wang J; Gassaway R; Nickbarg E; Kovacic S; Ciarletta A; Giannotti J; Finnerty H; Zollner R; Beier DR; Leak LV; Turner KJ; Wood CR
    Oncogene; 1997 Jul; 15(5):613-8. PubMed ID: 9247316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.
    Galland F; Karamysheva A; Pebusque MJ; Borg JP; Rottapel R; Dubreuil P; Rosnet O; Birnbaum D
    Oncogene; 1993 May; 8(5):1233-40. PubMed ID: 8386825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
    Takahashi T; Shibuya M
    Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
    Takahashi T; Yamaguchi S; Chida K; Shibuya M
    EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.
    Pajusola K; Aprelikova O; Korhonen J; Kaipainen A; Pertovaara L; Alitalo R; Alitalo K
    Cancer Res; 1992 Oct; 52(20):5738-43. PubMed ID: 1327515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).
    Yamane A; Seetharam L; Yamaguchi S; Gotoh N; Takahashi T; Neufeld G; Shibuya M
    Oncogene; 1994 Sep; 9(9):2683-90. PubMed ID: 8058332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
    Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.
    Gunningham SP; Currie MJ; Han C; Robinson BA; Scott PA; Harris AL; Fox SB
    Clin Cancer Res; 2000 Nov; 6(11):4278-86. PubMed ID: 11106244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade.
    Davis-Smyth T; Chen H; Park J; Presta LG; Ferrara N
    EMBO J; 1996 Sep; 15(18):4919-27. PubMed ID: 8890165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Apr; 15(7):1751. PubMed ID: 8612600
    [No Abstract]   [Full Text] [Related]  

  • 20. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
    Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
    Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.